PEOPLE - Changes at CryoCath:
This article was originally published in Clinica
Henri Vienneau, chairman of the board of directors for CryoCath (Montreal, Quebec), will act as interim president and CEO in place of Steven Arless, who has resigned to pursue other interests. Mr Arless was also a company director. Mr Vienneau has been a company director for seven years and chairman of the board for three. The firm creates minimally-invasive catheter- and probe-based cryotherapy products (the use of freezing temperatures to treat diseased tissue) focusing on cardiovascular disease.